Labrosse B, Treboute C, Brelot A, Alizon M
INSERM U.332, Institut Cochin de Génétique Moléculaire, 75014 Paris, France.
J Virol. 2001 Jun;75(12):5457-64. doi: 10.1128/JVI.75.12.5457-5464.2001.
Human immunodeficiency virus type 1 (HIV-1) entry is triggered by the interaction of the gp120 envelope glycoprotein with a cellular chemokine receptor, either CCR5 or CXCR4. We have identified different mutations in human CXCR4 that prevent efficient infection by one HIV-1 strain (NDK) but not another (LAI) and sought to define these strain-dependent effects at the gp120 level. The lack of activity toward the NDK strain of the HHRH chimeric CXCR4 in which the second extracellular loop (ECL2) derived from the rat CXCR4 and of CXCR4 with mutations at an aspartic acid in ECL2 (D193A and D193R) was apparently due to the sequence of the third variable loop (V3) of gp120, more precisely, to its C-terminal part. Indeed, substitution of the LAI V3 loop or only its C-terminal part in the NDK gp 120 context was sufficient to restore usage of the HHRH, D193A, and D193R receptors. The same result was achieved upon mutation of a single lysine residue of the NDK V3 loop to alanine (K319A) but not to arginine (K319R). These results provide a strong case for a direct interaction between the gp120 V3 loop and the ECL2 domain of CXCR4. By contrast, V3 substitutions had no effect on the inability of NDK to infect cells via a mutant CXCR4 in which the amino-terminal extracellular domain (NT) is deleted. In experiments with a set of chimeric NDK-LAI gp120s, the V1/V2 region from LAI gp120 was both necessary and sufficient for usage of the NT-deleted CXCR4. Different variable domains of gp120 can therefore cooperate for a functional interaction with CXCR4.
1型人类免疫缺陷病毒(HIV-1)的进入是由包膜糖蛋白gp120与细胞趋化因子受体CCR5或CXCR4相互作用引发的。我们在人类CXCR4中鉴定出不同的突变,这些突变可阻止一种HIV-1毒株(NDK)有效感染,但不影响另一种毒株(LAI),并试图在gp120水平上确定这些毒株依赖性效应。由大鼠CXCR4衍生的第二个细胞外环(ECL2)的HHRH嵌合CXCR4以及ECL2中天冬氨酸发生突变(D193A和D193R)的CXCR4对NDK毒株缺乏活性,这显然归因于gp120的第三个可变环(V3)序列,更确切地说是其C末端部分。实际上,在NDK gp120背景下替换LAI V3环或仅其C末端部分足以恢复HHRH、D193A和D193R受体的使用。将NDK V3环的单个赖氨酸残基突变为丙氨酸(K319A)可得到相同结果,但突变为精氨酸(K319R)则不然。这些结果有力地证明了gp120 V3环与CXCR4的ECL2结构域之间存在直接相互作用。相比之下,V3替换对NDK通过缺失氨基末端细胞外结构域(NT)的突变型CXCR4感染细胞的无能没有影响。在一组嵌合NDK-LAI gp120的实验中,LAI gp120的V1/V2区域对于使用缺失NT的CXCR4既是必需的也是足够的。因此,gp120的不同可变结构域可协同与CXCR4进行功能性相互作用。